Kikuchi-Fujimoto Disease Following COVID-19 Infection in a 7-Year-Old Girl: A Case Report and Literature Review
- PMID: 35936128
- PMCID: PMC9351715
- DOI: 10.7759/cureus.26540
Kikuchi-Fujimoto Disease Following COVID-19 Infection in a 7-Year-Old Girl: A Case Report and Literature Review
Abstract
The coronavirus disease 2019 (COVID-19) symptoms in children are relatively mild and often do not require treatment. Nonetheless, complications caused by the immune response to COVID-19 in children are possible and diverse. We present the case of a 7-year-old girl with persistent fever and lymphadenopathy arising from SARS-CoV-2 infection, diagnosed with Kikuchi-Fujimoto Disease (KFD) on lymph node biopsy. KFD is a rare benign disease, clinically characterized by fever and tender cervical lymphadenopathy affecting posterior cervical lymph nodes. We also reviewed six previously reported cases of COVID-19-associated KFD that occurred in school-aged children and compared them with the present case. The clinical course of COVID-19-associated KFD was similar to that of previous reports of KFD with a favorable prognosis. This is the first report of a school-aged child developing KFD following SARS-CoV-2 infection. KFD should be considered when approaching patients with hyperinflammatory states who present with prolonged fever and cervical lymphadenopathy after COVID-19.
Keywords: cervical lymphadenopathy; covid-19; histiocytic necrotizing lymphadenitis; kikuchi-fujimoto disease; sars-cov-2.
Copyright © 2022, Saito et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Kikuchi-Fujimoto disease following SARS-CoV-2 infection: A rare disease with increased incidence during the COVID-19 pandemic?Respirol Case Rep. 2024 Jun 19;12(6):e01414. doi: 10.1002/rcr2.1414. eCollection 2024 Jun. Respirol Case Rep. 2024. PMID: 38903947 Free PMC article.
-
Kikuchi-Fujimoto's Disease or Histiocytic Necrotizing Lymphadenitis Following mRNA COVID-19 Vaccination: A Rare Case.Cureus. 2022 Apr 15;14(4):e24155. doi: 10.7759/cureus.24155. eCollection 2022 Apr. Cureus. 2022. PMID: 35592214 Free PMC article.
-
Kikuchi-Fujimoto Disease: A Case of Febrile Cervical Lymphadenopathy With Hematological Abnormalities.Cureus. 2023 Oct 23;15(10):e47533. doi: 10.7759/cureus.47533. eCollection 2023 Oct. Cureus. 2023. PMID: 37877108 Free PMC article.
-
Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus complicated with macrophage activation syndrome: two case reports and a review of literature.BMC Pediatr. 2022 Nov 22;22(1):673. doi: 10.1186/s12887-022-03703-6. BMC Pediatr. 2022. PMID: 36414954 Free PMC article. Review.
-
A Case of Kikuchi-Fujimoto Disease in a 7-Year-Old African American Patient: A Case Report and Review of Literature.Am J Case Rep. 2020 Aug 24;21:e922784. doi: 10.12659/AJCR.922784. Am J Case Rep. 2020. PMID: 32830793 Free PMC article. Review.
Cited by
-
Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.Rev Esp Patol. 2024 Jan-Mar;57(1):42-47. doi: 10.1016/j.patol.2023.01.002. Epub 2023 Feb 28. Rev Esp Patol. 2024. PMID: 38246709 Free PMC article. Review.
-
Kikuchi-Fujimoto disease following SARS-CoV-2 infection: A rare disease with increased incidence during the COVID-19 pandemic?Respirol Case Rep. 2024 Jun 19;12(6):e01414. doi: 10.1002/rcr2.1414. eCollection 2024 Jun. Respirol Case Rep. 2024. PMID: 38903947 Free PMC article.
-
Kikuchi-Fujimoto disease following COVID-19 in a 32-year-old woman.J Clin Exp Hematop. 2023 Sep 28;63(3):209-211. doi: 10.3960/jslrt.23022. Epub 2023 Jul 28. J Clin Exp Hematop. 2023. PMID: 37518269 Free PMC article. No abstract available.
-
COVID-19 vaccine-associated lymphadenopathy: a review.Infez Med. 2024 Jun 1;32(2):119-130. doi: 10.53854/liim-3202-1. eCollection 2024. Infez Med. 2024. PMID: 38827838 Free PMC article. Review.
-
The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.Drug Saf. 2024 May;47(5):405-418. doi: 10.1007/s40264-024-01405-9. Epub 2024 Feb 23. Drug Saf. 2024. PMID: 38396269 Free PMC article.
References
-
- Epidemiology of COVID-19 among children in China. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Pediatrics. 2020;145:0. - PubMed
-
- COVID-19 exposure: a possible association with congenital anomalies and adverse neonatal outcomes. Satnarine T, Kin CML. JMHS. 2022;3:44–48.
-
- Cervical subacute necrotizing lymphadenitis. A new clinicopathological entity. Fujimoto Y, Kojima Y, Yamaguchi K. Naika. 1972;20:920–927.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous